stockcue

NBIX (Neurocrine Biosciences, Inc.): risk score 82/100 — Strong Buy · Valuation 62/100 · Financial health 98/100 · Growth 87/100 · price $167.77. Full report with peer comparison, earnings trends and AI analysis below.

Fetching report — first lookup can take ~5s